FDA Public Workshops of Interest: Biomarkers of Neurotoxicity on July 23 & Implementing FDA's Predictive Toxicology Roadmap on September 18
You are invited to attend an FDA public workshop planned for March 29, 2019 titled Leveraging Human-Relevant Cardiomyocytes in Nonclinical Studies to Provide Mechanistic Insights into Cardiovascular Safety Liabilities. Registration required by March 27.
The Food and Drug Administration is announcing the following public workshop entitled "Regulatory Perspectives on Otic and Vestibular Toxicity: Challenges in Translating Animal Studies to Human Risk Assessment.”
Staff Fellow, In Vivo Research Position - U.S. FDA
Silver Spring, Maryland, USA
We welcome participation from our colleagues who are members of Safety Pharmacology Society (SPS).